U.S Medical Affairs Outsourcing Market Share Analysis Report, 2023-2032
According to Nova one advisor, the U.S Medical Affairs Outsourcing Market Size was valued at USD 525.99 million in 2022 and is predicted to be worth USD 1,288.2 million by 2032, with a CAGR of 11.90% from 2023 to 2032.
Medical affairs is the department inside a pharmaceutical or medical device organization that informs healthcare professionals with reliable information. By using a technique called medical affairs outsourcing, patients, healthcare providers (HCPs), and governmental organizations may get deep knowledge of patient data as well as healthcare regulations and practices. The process of discovering and developing new drugs requires both money and time. It can take more than 10 to 15 years to complete the process from early discovery or design to development and regulatory approval. To ensure the quality and effectiveness of a drug substance, several testing services are needed. In order to cut costs and time, pharmaceutical and biotechnology companies choose to outsource their services to contract research organizations (CROs), which is predicted to accelerate the market's growth. The World Health Organization published statistics in 2019 showing an increase in the yearly number of clinical trials registered, from 3,344 in 2004 to 54,894 in 2018. The product’s efficiency and safety for human consumption is monitored by the outsourcing companies.
Report Scope of the U.S Medical Affairs Outsourcing Market
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 615.19 million |
|
Market Size by 2032 |
USD 1,288.2 million |
|
Growth Rate from 2023 to 2032 |
CAGR of 11.90% |
|
Base Year |
2022 |
|
Forecast Period |
2023 to 2032 |
|
Segments Covered |
|
Services Insights
Based on Services, the US Medical Affairs Outsourcing market is segmented into medical science liaisons, medical writing & publishing, medical information, and medical monitoring. The medical science liaisons (MSLs) market is estimated to grow at the fastest pace throughout the projected period due to the growing demand for professional medical writing, publication, and service supply from small, mid-sized, and major healthcare organizations.
Medical Science Liaisons are doctorate- and advanced-degree-holding healthcare professionals who act as regional extensions of medical affairs departments. They connect with stakeholders and healthcare experts and respond to their clinical queries about drugs, technologies, and the disorders they treat.
Industry Insights
Based on Industry, the US Medical Affairs Outsourcing market is segmented into pharmaceutical, biopharmaceutical, and medical devices. The medical devices are further segmented into therapeutic medical devices and diagnostic medical devices Therapeutic medical devices include any equipment, apparatus, appliance, or other items that are meant to be used by humans for a therapeutic purpose. A reagent, calibrator, control material, kit, specimen receptacle, software, instrument, apparatus, equipment, or system that is used alone or in combination with other diagnostic items for in vitro application is known as an in vitro diagnostic medical device (IVD). In 2022, the pharmaceutical industry held the larger market share. The demand for medical affairs providers has risen as a result of numerous patent expirations, for the development of new patent drafts in the US. The requirement for medical affairs outsourcing services in the market is anticipated to increase as a result of the biopharma industry's increased focus on the basic operations associated with drug development. The pandemic is expected to have a long-term impact on the pharmaceutical business, which has been facing poor growth, delayed medication approvals, and insufficient pharma manufacturing supply chain.
Some of the prominent players in the U.S Medical Affairs Outsourcing Market include:
Segments Covered in the Report
This report forecasts revenue growth and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S Medical Affairs Outsourcing market.
By Services
By Industry
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on US Medical Affairs Outsourcing Market
5.1. COVID-19 Landscape: US Medical Affairs Outsourcing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. US Medical Affairs Outsourcing Market, By Services
8.1. US Medical Affairs Outsourcing Market, by Services, 2023-2032
8.1.1. Medical Science Liaisons (MSLs)
8.1.1.1. Market Revenue and Forecast (2018-2032)
8.1.2. Medical Writing & Publishing
8.1.2.1. Market Revenue and Forecast (2018-2032)
8.1.3. Medical Monitoring
8.1.3.1. Market Revenue and Forecast (2018-2032)
8.1.4. Medical Information
8.1.4.1. Market Revenue and Forecast (2018-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2018-2032)
Chapter 9. US Medical Affairs Outsourcing Market, By Industry
9.1. US Medical Affairs Outsourcing Market, by Industry, 2023-2032
9.1.1. Pharmaceutical
9.1.1.1. Market Revenue and Forecast (2018-2032)
9.1.2. Biopharmaceutical
9.1.2.1. Market Revenue and Forecast (2018-2032)
9.1.3. Medical Devices
9.1.3.1. Market Revenue and Forecast (2018-2032)
9.1.4. Therapeutic Medical devices
9.1.4.1. Market Revenue and Forecast (2018-2032)
9.1.5. Diagnostic medical devices
9.1.5.1. Market Revenue and Forecast (2018-2032)
Chapter 10. US Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast
10.1. US
10.1.1. Market Revenue and Forecast, by Services (2018-2032)
10.1.2. Market Revenue and Forecast, by Industry (2018-2032)
Chapter 11. Company Profiles
11.1. Pharmaceutical Product Development, LLC
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. IQVIA Holdings Inc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SGS SA
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ZEINCRO Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Pfizer Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. The Medical Affairs Company
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ICON plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ashfield Healthcare Communications
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Syneos Health Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Wuxi Clinical Development, Inc
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers